Author

IJ Diel

Observed names: I Diel, I J Diel, I. Diel, I. J. Diel, I.J Diel, I.J. Diel

Observed institutions: German Cancer Research Center, Heidelberg University, University Hospital Heidelberg, Sana Kliniken AG, Frauenklinik Heidelberg, Universitäts Frauenklinik, German Breast Group, Sana Klinikum Offenbach, Helios Hospital Berlin-Buch, Agaplesion Diakonieklinikum Rotenburg, Martin Luther University Halle-Wittenberg

OpenAlex ID: A5046696381

Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.

1999 · I J Diel, E F Solomayer, et al. · PubMed · 117

Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients.

2001 · E F Solomayer, I J Diel, et al. · PubMed · 50

Interaction of psychosocial and physical risk factors in the causation of mammary cancer, and its prevention through psychological methods of treatment

2000 · R. Grossarth-Maticek, H. J. Eysenck;, et al. · Journal of Clinical Psychology · 50

Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancer

1998 · E-F. Solomayer, I.J. Diel, et al. · Breast Cancer Research and Treatment · 28

S2-4: GAIN Study: A Phase III Trial To Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients with Node-Positive Primary Breast Cancer – 1st Interim Efficacy Analysis.

2011 · V Möbus, IJ Diel, et al. · Cancer Research · 22

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

2003 · J.-J. Body, I.J. Diel, et al. · Annals of Oncology · 21

Markers of bone turnover do not predict bone metastases in breast cancer.

2002 · M J Seibel, M Koeller, et al. · PubMed · 17

Long-term variability of bone turnover markers in patients with non-metastatic breast cancer.

2002 · M J Seibel, M Koeller, et al. · PubMed · 14

Interaction of psychosocial and physical risk factors in the causation of mammary cancer, and its prevention through psychological methods of treatment

2000 · R. Grossarth-Maticek, H. J. Eysenck;, et al. · Journal of Clinical Psychology · 8

Long-term (4-year) safety of intravenous Ibandronate in metastatic breast cancer: an open-label study

2004 · M Pecherstorfer, I.J Diel, et al. · European Journal of Cancer Supplements · 6

Evidence-Based Recommendations on Treating Locoregional and Distant Metastases of Carcinomas of the Breast

2002 · G. von Minckwitz, S. D. Costa, et al. · Zentralblatt für Gynäkologie · 4

Lymphangiosis carcinomatosa der Haut beim Ovarialkarzinom unter dem klinischen Bild einer Sklerodermie

1991 · I. Diel, W. Kühn, et al. · Geburtshilfe und Frauenheilkunde · 3

St.-Gallen-Konferenz 2009 zum primären Mammakarzinom

2009 · M. Beckmann, J.-U. Blohmer, et al. · Geburtshilfe und Frauenheilkunde · 2

0-3. Prognostic impact of tumour cell detection in patients with early (T1) and locally advanced breast cancer

1997 · I.J. Diel, E.F. Solomayer, et al. · The Breast · 2

Prospective randomized studies are needed to define the role of axillary lymph node dissection in primary breast cancer.

1997 · S D Costa, G von Minckwitz, et al. · Journal of Clinical Oncology · 2

Interdisziplinäres Konsensuspapier zum adjuvanten Einsatz von Bisphosphonaten bei Mammakarzinom-Patientinnen

2009 · I. Diel, G. Dresemann, et al. · Geburtshilfe und Frauenheilkunde · 1

Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11 th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer) 2009 St. Gallen Conference: Primary Therapy of Early Breast Cancer - Opinion among Germ

2009 · MW Beckmann, Jens‐Uwe Blohmer, et al. · mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) · 1

Cellular immunotherapy in late stage breast cancer patients with reactivated autologous Memory T-cells (MTC) derived from bone marrow (BM) (Phase-I trail)

2004 · K Ehlert, P Beckhove, et al. · Zentralblatt für Gynäkologie · 1

Intravenous and oral ibandronate reduce the risk of skeletal-related events (SREs) in patients with breast cancer and bone metastases

2004 · D Tripathy, J.-J Body, et al. · European Journal of Cancer Supplements · 1

Radiation enhancement of Gemcitabine® In three human cervical cancer cell lines

1997 · D. Wallwiener, R. Kurek, et al. · European Journal of Cancer · 1

Tumor cell detection in breast cancer patients before and after neoadjuvant chemotherapy

1997 · E.-F. Solomaver, I.J. Diel, et al. · European Journal of Cancer · 1

Denosumab And Bisphosphonates Persistence, Compliance And Switch In Patients With Solid Tumors (ST) And Bone Metastases (BM)

2017 · I Diel, S Ansorge, et al. · Value in Health

Denosumab for the prevention of symptomatic skeletal events (SSEs) in patients with bone-metastatic breast cancer: A comparison with skeletal-related events (SREs)

2016 · J.-J. Body, R. von Moos, et al. · Annals of Oncology

Real-Life-Daten zur Behandlung von Knochenmetastasen bei Patientinnen mit Mammakarzinom in Deutschland – Darstellung des Versorgungsalltags

2015 · I Diel, P Feyer, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie

Einfluss einer Prävention skelettbezogener Komplikationen mit Denosumab auf die Krankenhausaufenthalte von Patienten mit Mammakarzinom und Knochenmetastasen in Deutschland

2015 · I Diel, R Ikenberg, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie

Works count: 56

Citation count: 352

H-index: 8

I10-index: 8